Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Other Non Operating Income (2017 - 2021)

Cogent Biosciences has reported Other Non Operating Income over the past 5 years, most recently at $621000.0 for Q4 2021.

  • Quarterly results put Other Non Operating Income at $621000.0 for Q4 2021, up 15.0% from a year ago — trailing twelve months through Dec 2021 was $2.5 million (up 215.6% YoY), and the annual figure for FY2025 was -$20000.0, changed.
  • Other Non Operating Income for Q4 2021 was $621000.0 at Cogent Biosciences, roughly flat from $620000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for COGT hit a ceiling of $623000.0 in Q2 2021 and a floor of -$10000.0 in Q4 2018.
  • Median Other Non Operating Income over the past 5 years was $91000.0 (2017), compared with a mean of $230941.2.
  • Biggest five-year swings in Other Non Operating Income: plummeted 110.99% in 2018 and later surged 13600.0% in 2020.
  • Cogent Biosciences' Other Non Operating Income stood at $91000.0 in 2017, then plummeted by 110.99% to -$10000.0 in 2018, then surged by 60.0% to -$4000.0 in 2019, then surged by 13600.0% to $540000.0 in 2020, then rose by 15.0% to $621000.0 in 2021.
  • The last three reported values for Other Non Operating Income were $621000.0 (Q4 2021), $620000.0 (Q3 2021), and $623000.0 (Q2 2021) per Business Quant data.